COLLEEN OVERSTREET: Open Payments
NPI 1922767763 · HYANNIS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,525 in 64 payments from 13 companies in 2025. Trend: 2023 $505 · 2024 $566 · 2025 $1,525
Food & beverage: $1,525
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $401 |
| PFIZER INC. | 14 | $165 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $162 |
| Novo Nordisk Inc | 5 | $161 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $122 |
| Novartis Pharmaceuticals Corporation | 6 | $120 |
| E.R. Squibb & Sons, L.L.C. | 5 | $115 |
| Alnylam Pharmaceuticals Inc. | 4 | $82 |
| SCPHARMACEUTICALS INC. | 3 | $64 |
| HEARTFLOW, INC. | 2 | $56 |
Products named: Repatha, LifeVest, Wegovy, VYNDAQEL, Kerendia, LEQVIO, CAMZYOS, ELIQUIS.
Industry payments across MA — which companies pay providers there.
